newsfilter
← Latest News
GlobeNewswire·

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

  • Abeona Therapeutics Inc. (Nasdaq: ABEO) announced management participation in two investor conferences in November 2026.
  • The Stifel 2026 Healthcare Conference features a fireside chat on Wednesday, November 11, 2026, at 8:40 AM ET.
  • The Jefferies Global Healthcare Conference includes a presentation on Wednesday, November 18, 2026, at 10:30 AM GMT.
  • Live webcasts & replays for both events will be available on the company's investor website under the Events section.
  • Abeona's portfolio includes ZEVASKYN, an autologous gene therapy for recessive dystrophic epidermolysis bullosa.
  • The company's pipeline also features ABO-801, a Phase 3-ready candidate for eosinophilic esophagitis.
  • ABO-701 is an investigational engineered T-cell therapy targeting PSMA.
Company
Abeona Therapeutics Inc.
Keywords
Nasdaq:ABEO, Abeona Therapeutics Inc.